By delivering high doses of treatment quickly and painlessly directly to the tumour, Papillon gives bowel, skin & other accessible tumour cancer patients a real choice. 40,000 people a year get bowel cancer, nearly 9000 have surgery. If eligible, Papillon avoids the high operative mortality (10-20%) and morbidity (30-50%) especially in the elderly which radical surgery can pose. Papillon is also used in the treatment of some skin cancers & inter-operative breast cancer.